maintain hold post solid result mark enrol growth across
product sg beat solid cf ep upsid guidanc rais risk-
base enrol specialti growth aid strong commerci result
timing/transi dilut impact government biz remain upbeat
segment prospect addit near-term launch ingeniorx bring
combin pharmacy/med benefit coupl dbg asset
view well posit on-going move toward vbc
tweak pt vs tie pure market multipl
commerci busi post strong grow enrol
member increas oper gain result benefit
compani new streamlin product offer enhanc
on-line shop portal broker tool return growth risk-
base group membership stabl medic cost administr fee also
outpac fee-bas membership increas increas penetr
valu ad servic specialti product dental vision behavior
stop loss clinic program aid margin see attract
opportun drive increment penetr specialti servic
time compani work lower current risk based/fe base
contribut ratio would expect on-going progress fuel earn
lower cost increas satisfact improv outcom
like growth prospect move piec neg impact
govern busi remain bullish segment continu
see sever inher growth tail wind quarter impact non-
recurr retroact revenu adjust seen elev medic
cost select medicaid state factor invest group
new medicaid state entri mn result reduct oper
incom yoy manag expect return normal growth
balanc year enrol remain strong increas
member medicaid cost trend elev select state oper
margin remain within target level win rate remain impress
bolster recent nc statewid contract award washington dc
re-procur addit compani expect see actuari sound
rate iowa begin see solid uptick membership
state given buy pend exit medicar
busi saw anoth growth enrol manag
reiter full year growth target individu group
compani also launch social determin health benefit packag
nutrit transport adult daycar in-hom care expect
tr target
tr target includ dividend
aid membership growth particularli complex/chron patient improv outcom
lower cost given secular tailwind age demograph mix shift toward potenti
partnership opportun uniqu posit within group expect medicar
compani expect begin transit member intern pbm ingeniorx may full
membership migrat conclud continu expect meaning gross save
accru sharehold remain bullish launch tie combin medical/
pharmaci benefit improv care coordin reduc gap care increas adher
aid visibl around pharmaci also like addit member touch point expect
improv pharmaci cost structur posit compani well strong busi trend
cost care complex popul rise shift toward valu base care on-going expect
ingeniorx diversifi busi group grow increasingli valuabl platform
continu view dbg set asset potenti appreci highli differenti
advanc analyt healthcar clinic pathway solut aim high tough care deliveri
caremor reduc cost improv outcom drive growth opportun provid
necessari tool oper valu base model
solid print bump full year guidanc result look solid in-lin oper
revenu yoy membership growth across segment uptick administr
fee valu ad servic specialti mbr came strhe consensu
bit better estim combin much better sg cost manag
vs strhe drove better expect oper gain modestli lower tax rate
share count augment bottom line adjust ep come ahead
estim consensu follow better expect result manag
rais full year adjust ep greater greater tie result
solid rais estim cffo solid come
respect compani continu expect gener cffo day claim
payabl day day yoy day sequenti expect
addit debt/cap exit compani repurchas share common stock
paid quarterli dividend per share given solid cash flow financi
flexibl would expect capit deploy remain on-going compani five year
deploy guidanc flexibl deploy share buyback dividend serv
rough road map bump adjust ep estim reflect
result updat guidanc
page
oper revenu
oper revenu
total oper revenu
revenu
 includ sg
amort intang
revenu
revenu
page
lead provid healthcar benefit specialti product commerci
govern membership commerci compani largest busi segment member
compani boast signific local market share strong brand recognit also
sizabl medicaid presenc member grow medicar advantag product bolster
acquisit america choic healthsun compani launch full suit pbm
solut ingeniorx may gradual roll begin
like antm scale local market share view bcb brand differenti think
initi new manag drive improv across sever area still
work done compani work intern pbm function ingeniorx addit
view commerci market sizabl profit contributor highli competit tougher
growth market new pbm initi could take time view risk/reward balanc
reiter hold
valuat risk
trade ep discount manag care group averag view
appropri given compani exposur highli competit tougher growth commerci
market price target base trade ep premium
current multipl tie compani scale brand recognit local market share expect futur
benefit pharmaci upsid risk includ better expect growth govern busi
share gain commerci stronger pbm growth downsid risk includ increas pressur
commerci market advers regulatory/legisl chang difficulti grow govern pay
busi slower pbm ramp
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
